Canada markets closed

X4 Pharmaceuticals, Inc. (XFOR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1500+0.0700 (+6.48%)
At close: 04:00PM EDT
1.1400 -0.01 (-0.87%)
After hours: 07:30PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 193.13M
Enterprise Value 137.19M
Trailing P/E 5.49
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.78
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.45

Trading Information

Stock Price History

Beta (5Y Monthly) 0.46
52-Week Change 3-33.74%
S&P500 52-Week Change 322.38%
52 Week High 32.5750
52 Week Low 30.5720
50-Day Moving Average 31.1484
200-Day Moving Average 31.0441

Share Statistics

Avg Vol (3 month) 33.14M
Avg Vol (10 day) 35.95M
Shares Outstanding 5167.94M
Implied Shares Outstanding 6167.94M
Float 8130.2M
% Held by Insiders 10.83%
% Held by Institutions 160.84%
Shares Short (Apr 15, 2024) 412.26M
Short Ratio (Apr 15, 2024) 42.97
Short % of Float (Apr 15, 2024) 47.32%
Short % of Shares Outstanding (Apr 15, 2024) 47.30%
Shares Short (prior month Mar 15, 2024) 414.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 14, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Mar 14, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.38%
Return on Equity (ttm)-161.67%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -107.1M
Net Income Avi to Common (ttm)-101.17M
Diluted EPS (ttm)-0.5700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)114.22M
Total Cash Per Share (mrq)0.68
Total Debt (mrq)58.28M
Total Debt/Equity (mrq)114.06%
Current Ratio (mrq)5.34
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-96.51M
Levered Free Cash Flow (ttm)-59.79M